Jackson DJ, Bacharier LB, Gergen PJ, Gagalis L, et al. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet 2022;400:502-511.
PMID: 35964610